Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming - Wikidata - awgldk - TriplyDB

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming

http://www.wikidata.org/entity/Q34575700

about

Muse cells and induced pluripotent stem cell: implication of the elite model Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes Induction of pluripotency by defined factors Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells Present and future challenges of induced pluripotent stem cells Overcoming the hurdles for a reproducible generation of human functionally mature reprogrammed neurons Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies GPAT2, a mitochondrial outer membrane protein, in piRNA biogenesis in germline stem cells Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.The elite and stochastic model for iPS cell generation: multilineage-differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells.Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.Transgene excision has no impact on in vivo integration of human iPS derived neural precursors Turning straw into gold: directing cell fate for regenerative medicine.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.Methods for iPS cell generation for basic research and clinical applications.Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells.Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells.Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential.Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders.Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs.Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics.An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils.Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.Application of Induced Pluripotent Stem Cells in Liver Diseases Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture.Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells.

P2860

Q24625690-33123339-FAA4-478A-84EE-4EDE74989727 Q26750663-A3853FBE-3812-4EA5-B14F-CB779D5BB23C Q26769878-AE5983E1-A273-4DAA-8266-5B1BD978C8BE Q26784188-61B6B60F-ECDA-4AB0-B4F0-A6171973DD1D Q26830425-7EC3898F-61CB-4843-9544-872E1A48D08D Q26861563-C5DB2A5E-1C4A-4272-BAF2-31DA144FF90E Q27025379-E4900CF4-6CC0-47C8-88D4-8CF881F25E9C Q28066087-453E0431-4BA2-4418-BEF3-2F747C4DA0AC Q28073143-073AA3CF-AC1A-4FFA-BD86-E67F060380A9 Q28081565-24D3C7D5-A260-4216-92DD-D93AB72BDB25 Q28081651-3AE0039E-6203-4C3A-9011-0B2DAC0CDBA6 Q28082747-87E3F906-5C4C-44A3-8416-053F3DEE8D22 Q28083762-66FA401C-37D7-4F66-B9CB-565D6DBBEB68 Q28085565-3FAB6361-7F65-47A4-9D16-B5B40900566F Q28854373-A5B631DA-506F-4DC2-8691-186366EF1F30 Q34028987-F7E2C667-8445-4E72-9D3C-6331EC429C86 Q34032363-1509529C-E596-49DA-98F5-76FAF316C44F Q34033280-FB0AE369-ABA0-4A15-BA30-4551B1B637A4 Q34035837-79047DBA-4096-4CB3-9E31-989F93A15DE6 Q34169386-2530C871-FB3B-49F5-864B-29C5B4387557 Q34231818-10E632E7-F29E-4914-8599-595169F5F285 Q34257813-CCD1E83C-2B08-4D53-A327-B6BC2AC183E1 Q34530121-309D8770-92ED-4487-B0D6-1111875C5930 Q34601581-ED7DDCB7-793E-4A4D-BF57-B3E47793C140 Q34601924-C2C97771-A5A9-4BB8-B23A-EC4E36125FF8 Q34661781-E0B16137-A5D0-48A4-B58A-6C8B055E9802 Q34738075-6CBCD908-FB86-4A88-A93F-EA7E6D453463 Q34752070-0A9288AD-C111-46FC-A32F-E35EE0AFF4D0 Q35653333-CD10AEFF-BDAE-40A7-A805-BD6CA98EEC6C Q35878885-076CFB1A-C597-4DD3-A6A8-49537D163CD2 Q35896332-CC719E43-2216-42B6-B7EE-15C0D716EBAD Q36023026-BD2E6F02-89C9-4FD5-BC6D-FE36B560A995 Q36169226-5DAF0F4A-5D5F-4229-8A19-3B02C41A6CE8 Q36335777-D46D50D0-81B9-41A9-8BB8-10E05A332003 Q36358611-656BC1A4-583B-4EAF-8575-FF363D0A1DB5 Q36362642-29BFFE32-1D23-4018-9295-BB5B4C828F42 Q36379316-631EB4F1-D1FB-424E-92B5-2ED3EC098D27 Q36523507-CF5A0190-3390-4244-8485-60F8DAB593C5 Q36558882-0729FA75-2830-42B2-B5F4-04FDD4404DA3 Q36570136-9A75892D-3392-48A3-B182-C88A5B4A27D1

P2860

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming

http://www.wikidata.org/entity/Q34575700

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Development of defective and p ...... m ideal for cell reprogramming

@ast

Development of defective and p ...... m ideal for cell reprogramming

@en

Development of defective and p ...... m ideal for cell reprogramming

@nl

type

label

Development of defective and p ...... m ideal for cell reprogramming

@ast

Development of defective and p ...... m ideal for cell reprogramming

@en

Development of defective and p ...... m ideal for cell reprogramming

@nl

prefLabel

Development of defective and p ...... m ideal for cell reprogramming

@ast

Development of defective and p ...... m ideal for cell reprogramming

@en

Development of defective and p ...... m ideal for cell reprogramming

@nl

P1433

Q34575700-FB290969-BC9E-4203-958E-D61C9E54C4B3

P1476

Q34575700-0CFFBD04-35CA-49B0-85C8-6115E3479AB1

P2093

Q34575700-0F1AA0C0-7231-4A09-8D6C-0740065E96FC

Q34575700-194BAE5E-9F48-4DFF-BFE3-A259E5B96BE6

Q34575700-286A95AD-F72D-4286-8747-DEB2F5A31DE3

Q34575700-32BB25DA-CE9B-4179-B82D-14AA0B7395FE

Q34575700-4A2FAD27-4247-4012-AB61-9D392589F47E

Q34575700-525861AF-A57D-405A-8CE4-447D0BD55D75

Q34575700-598A539C-791B-45E2-B250-CC072ECE00CD

Q34575700-780BDCBB-7CCE-483F-949C-B0101995E63C

Q34575700-AB2B0328-14AE-442D-B539-C41D362A8B7F

Q34575700-B777D572-FA16-4577-8B21-2FFAD2AB4BEC

P2860

Q34575700-014F2255-F755-46C6-8AEC-86F3095FF779

Q34575700-02E99E3C-92BF-402B-A63F-D729A9489219

Q34575700-03A7CE97-B016-4CEF-B75D-16093D3182D1

Q34575700-08BF3065-D542-40E4-9D86-59EA38D31427

Q34575700-0E2D972D-2B79-4AD8-8389-8278A3976273

Q34575700-0F6A133D-7C08-4CCD-A59C-3D9FF39979D5

Q34575700-1011F0B3-B367-4A44-920C-AC514581FD00

Q34575700-15105E2A-2A93-4EA6-804A-66F6E2FB9C3A

Q34575700-159F0B74-20CF-49F4-87B1-49ED67F7A9B3

Q34575700-2B751DAE-F137-4B7E-A4BB-BE58F52AF7B9

P304

Q34575700-93D25C45-0C00-4BD1-BE27-B8732D0A1569

P31

Q34575700-4E22DCC2-9EB7-43E5-85CD-7FDE5DA68277

P356

Q34575700-E156A708-802B-4EF3-B54E-1275CCBB2DE5

P407

Q34575700-2E57A76A-98B7-442A-85A1-28F138971AC2

P433

Q34575700-6C78116C-4FE4-4BC2-9EF0-F81AA3F080C3

P478

Q34575700-4882FABD-6E1A-4596-B9A1-45D68F3485BB

P50

Q34575700-02E8A858-9242-44DB-B8EA-A37910F14C22

Q34575700-A150DED7-976D-4E20-BA8D-DB9AA9289ECB

Q34575700-CF93C3A1-A509-4C1D-88C7-CA5D64DB91EF

Q34575700-D625369D-80BB-4574-BB78-49BBF9CD453C

P577

Q34575700-53E724B2-00BD-44E7-BE28-374AA152714F

P698

Q34575700-0B37565E-162C-495F-AF23-9CBA29B0F7EF

P921

Q34575700-018E4F28-5D77-4065-B510-FE41D7CA0C97

Q34575700-F9312544-6897-4658-A0C2-562F3F7C1980

P932

Q34575700-45137D57-FF12-444D-9329-8622E168C824

P356

JBC.M110.183780

P1433

Journal of Biological Chemistry

P1476

Development of defective and p ...... m ideal for cell reprogramming

@en

P2093

Birei Furuta

http://www.w3.org/2001/XMLSchema#string

Eriko Uchida

http://www.w3.org/2001/XMLSchema#string

Hideyuki Sato

http://www.w3.org/2001/XMLSchema#string

Hiroaki Segawa

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Nakauchi

http://www.w3.org/2001/XMLSchema#string

Kaori Motomura

http://www.w3.org/2001/XMLSchema#string

Ken Nishimura

http://www.w3.org/2001/XMLSchema#string

Manami Ohtaka

http://www.w3.org/2001/XMLSchema#string

Satoko Takayasu

http://www.w3.org/2001/XMLSchema#string

Teruhide Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Pattern recognition receptors and inflammation

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Generation of germline-competent induced pluripotent stem cells

Human induced pluripotent stem cells free of vector and transgene sequences

Generation of mouse induced pluripotent stem cells without viral vectors

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

P304

4760-4771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.183780

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P50

Makoto Asashima

Mahito Nakanishi

P577

2010-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21138846

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

3039346

http://www.w3.org/2001/XMLSchema#string